Tim Vervliet

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Venues

Journal of cell science

Science signaling

British journal of pharmacology

KU Leuven

KU Leuven (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KU Leuven

Belgium

Post doctoral researcher :: cellular molecular medicine

Education History

KU Leuven Oct 01 2010 - Sep 30 2015

Belgium

PHD :: Cellular Molecular Medicine

Publications

Tim Vervliet, Robin Duelen, Ankit Pradhan, Rita La Rovere, H Llewelyn Roderick, Maurilio Sampaolesi
Cardiomyocyte differentiation from human induced pluripotent stem cells is delayed following knockout of Bcl-2. Journal of cell science 136 (2) (2023)
Tim Vervliet, Robin Duelen, Ankit Pradhan, Rita La Rovere, H Llewelyn Roderick, Maurilio Sampaolesi
Cardiomyocyte differentiation from human induced pluripotent stem cells is delayed following knockout of Bcl-2. Journal of cell science 136 (2) (2023)
Tim Vervliet, Robin Duelen, Ankit Pradhan, Rita La Rovere, H Llewelyn Roderick, Maurilio Sampaolesi
Cardiomyocyte differentiation from human induced pluripotent stem cells is delayed following knockout of Bcl-2. Journal of cell science 136 (2) (2023)
Tim Vervliet, Robin Duelen, Ankit Pradhan, Rita La Rovere, H Llewelyn Roderick, Maurilio Sampaolesi
Cardiomyocyte differentiation from human induced pluripotent stem cells is delayed following knockout of Bcl-2. Journal of cell science (2022)
Jens Loncke, Tim Vervliet, Jan B Parys, Allen Kaasik, Geert Bultynck
Uniting the divergent Wolfram syndrome-linked proteins WFS1 and CISD2 as modulators of Ca2+ signaling. Science signaling 14 (702) (2021)
Monika A Jakubowska, Martijn Kerkhofs, Claudio Martines, Dimitar G Efremov, Julia V Gerasimenko, Oleg V Gerasimenko, Ole H Petersen, Geert Bultynck, Tim Vervliet, Pawel E Ferdek
ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca2+ -signalling dysregulation or toxicity in pancreatic acinar cells. British journal of pharmacology 176 (22) (2018)

Tim Vervliet.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tim Vervliet